Annette North - 30 Aug 2021 Form 4 Insider Report for Turning Point Therapeutics, Inc.

Role: EVP, General Counsel & Secty.
Signature: /s/ Annette North
Issuer symbol: N/A
Transactions as of: 30 Aug 2021
Net transactions value: -$630,000
Form type: 4
Filing time: 31 Aug 2021, 17:26:57 UTC
Previous filing: 16 Jun 2021
Next filing: 11 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TPTX	Common Stock	Options Exercise	$170,000	+10,000	+81%	$17.00	22,365	30 Aug 2021	Direct	F1
transaction	TPTX	Common Stock	Sale	$800,000	-10,000	-45%	$80.00	12,365	30 Aug 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TPTX	Stock Option (right to buy)	Options Exercise	$0	-10,000	-6.5%	$0.000000	144,609	30 Aug 2021	Common Stock	10,000	$17.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on November 16, 2020.
F2	One-fourth of the option vested on April 15, 2020. Thereafter, 1/48th of the Option vests on a monthly basis over 36 months until the option becomes fully vested.